DCs are key antigen-presenting cells in the human body and have played an important role as important targets in previous tumor immunotherapy, with the main mechanism being the mediation of tumor immunity through the activation of CD8+ and CD4+ T cells (15). This evidence concerns the gene CD8A and neoplasm.